| known also as: |
Calcium Release-Activated Calcium Channel Protein 1), TMEM142A, Anti-ORAI1 (Transmembrane Protein 142A |
| known also as: |
Calcium Release-Activated Calcium Channel Protein 1), TMEM142A, ORAI1 (Transmembrane Protein 142A |
| known also as: |
Calcium Release-Activated Calcium Channel Protein 1), TMEM142A, ORAI1 (Transmembrane Protein 142A |
| known also as: |
ORAI1 |
| known also as: |
Calcium Release-Activated Calcium Channel Protein 1), TMEM142A, Anti -ORAI1 (Transmembrane Protein 142A |
| Other names: |
Calcium release-activated calcium channel protein 1, ORAI calcium release-activated calcium modulator 1, OTTHUMP00000240038, Protein orai-1, Transmembrane protein 142A, calcium release-activated calcium channel protein 1, calcium release-activated calcium modulator 1, protein orai-1, transmembrane protein 142A, ORAI1 protein |
| Other gene names: |
CRACM1, CRACM1, FLJ14466, ORAI1, ORAT1, TMEM142A, TMEM142A, ORAI1 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Immunoglobulin isotype: |
IgG |
| Clone: |
Polyclonal antibody |
| Host organism: |
Source: Human, Host: Rabbit |
| Species reactivity: |
Mouse, Human |
| Specificity and cross-reactivity: |
Predicted to have no crossreactivity to ORAI2 or ORAI3, Species Crossreactivity: Mouse, Recognizes human ORAI1 |
| Purification method: |
Affinity Purified by immunoaffinity chromatography |
| Form/Appearance: |
0, before the addition of glycerol to 40%, 02% sodium azide, Supplied as a liquid in PBS |
| Storage and shipping: |
For maximum recovery of product, Further dilutions can be made in assay buffer, Long-term storage should be done after aliquoting the item and freezing the aliqotes at -20 degrees Celsius, Under these conditions the aliquots will be stable for at least one year if kept at -20 °, centrifuge the original vial after thawing and prior to removing the cap, C, Store at 4 degrees Celsius for short term storage |
| Tested for:: |
Immunohistochemistry (IHC), Western Blot (WB), ELISA (EL/EIA) |
| Description: |
Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Gene target: |
Calcium Release-Activated Calcium Channel Protein 1), TMEM142A, ORAI1 (Transmembrane Protein 142A |
| Short name: |
Calcium Release-Activated Calcium Channel Protein 1), TMEM142A, ORAI1 (Transmembrane Protein 142A |
| Alternative name: |
Calcium Release-Activated Calcium Channel Protein 1), TMEM142A, ORAI1 (Transmembrane Protein 142A |
| Identity: |
25896 |
| Gene: |
ORAI1 |
More about : ORAI1 |
| Long gene name: |
ORAI calcium release-activated calcium modulator 1 |
| Synonyms gene: |
TMEM142A |
| Synonyms gene name: |
transmembrane protein 142A |
| Synonyms: |
FLJ14466 CRACM1 |
| Synonyms name: |
calcium release-activated calcium modulator 1 |
| Locus: |
12q24, 31 |
| Discovery year: |
2006-04-10 |
| GenBank acession: |
AK027372 |
| Entrez gene record: |
84876 |
| Pubmed identfication: |
16582901 |
| RefSeq identity: |
NM_032790 |
| Classification: |
ORAI calcium release-activated calcium modulators |
| Havana BLAST/BLAT: |
OTTHUMG00000169073 |
| Locus Specific Databases: |
ORAI1base: Mutation registry for severe combined immunodeficiency LRG_93 |